Thomas Lance R, Wang Qingguo, Grieb Brian C, Phan Jason, Foshage Audra M, Sun Qi, Olejniczak Edward T, Clark Travis, Dey Soumyadeep, Lorey Shelly, Alicie Bethany, Howard Gregory C, Cawthon Bryan, Ess Kevin C, Eischen Christine M, Zhao Zhongming, Fesik Stephen W, Tansey William P
Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Mol Cell. 2015 May 7;58(3):440-52. doi: 10.1016/j.molcel.2015.02.028. Epub 2015 Mar 26.
MYC is an oncoprotein transcription factor that is overexpressed in the majority of malignancies. The oncogenic potential of MYC stems from its ability to bind regulatory sequences in thousands of target genes, which depends on interaction of MYC with its obligate partner, MAX. Here, we show that broad association of MYC with chromatin also depends on interaction with the WD40-repeat protein WDR5. MYC binds WDR5 via an evolutionarily conserved "MYC box IIIb" motif that engages a shallow, hydrophobic cleft on the surface of WDR5. Structure-guided mutations in MYC that disrupt interaction with WDR5 attenuate binding of MYC at ∼80% of its chromosomal locations and disable its ability to promote induced pluripotent stem cell formation and drive tumorigenesis. Our data reveal WDR5 as a key determinant for MYC recruitment to chromatin and uncover a tractable target for the discovery of anticancer therapies against MYC-driven tumors.
MYC是一种癌蛋白转录因子,在大多数恶性肿瘤中均有过表达。MYC的致癌潜能源于其与数千个靶基因中的调控序列结合的能力,而这依赖于MYC与其专一性伴侣MAX的相互作用。在此,我们表明MYC与染色质的广泛关联同样依赖于与WD40重复蛋白WDR5的相互作用。MYC通过一个进化保守的“MYC盒IIIb”基序与WDR5结合,该基序与WDR5表面一个浅的疏水裂隙相互作用。MYC中破坏与WDR5相互作用的结构导向突变会减弱MYC在其约80%染色体位置上的结合,并使其促进诱导多能干细胞形成和驱动肿瘤发生的能力丧失。我们的数据揭示WDR5是MYC募集至染色质的关键决定因素,并为发现针对MYC驱动肿瘤的抗癌疗法揭示了一个易于处理的靶点。